(Q43700878)

26 November 2017

title

BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia (English)

1 reference

26 November 2017

main subject

Gram-negative bacteria

0 references

1 reference

1 reference

Michael S Niederman

1

1 reference

26 November 2017

Jean Chastre

2

1 reference

26 November 2017

Kevin Corkery

3

1 reference

26 November 2017

James B Fink

4

1 reference

26 November 2017

Charles-Edouard Luyt

5

1 reference

26 November 2017

Miguel Sánchez García

6

1 reference

26 November 2017

publication date

7 December 2011

1 reference

26 November 2017

number of pages

9

1 reference

inferred from page(s)

published in

Intensive Care Medicine

1 reference

26 November 2017

volume

38

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

263-271

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-011-2420-0

26 November 2017

exact match

0 references

cites work

Ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Overview of nosocomial infections caused by gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Technical report: precautions regarding the use of aerosolized antibiotics. Committee on Infectious Diseases and Committee on Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Interpretation of antibiotic concentration ratios measured in epithelial lining fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2420-0

Pharmacokinetics and tolerability of BAY41-6551 in subjects with chronic kidney disease

21 January 2018

1 reference

12 December 2020

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

12 December 2020

Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited

1 reference

12 December 2020

The therapeutic monitoring of antimicrobial agents

1 reference

12 December 2020

Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with gram-negative pneumonia and acute renal failure

1 reference

12 December 2020

The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia

1 reference

12 December 2020

Laboratory guidelines for monitoring of antimicrobial drugs. National Academy of Clinical Biochemistry

1 reference

12 December 2020

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum

1 reference

12 December 2020

The pharmacodynamics of aminoglycosides

1 reference

12 December 2020

10.1007/S00134-011-2420-0

Identifiers

DOI

1 reference

26 November 2017

1 reference